Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedNew navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added and the page revision updated to Revision: v3.6.0. The personnel attribution was adjusted, with Shen Lin appearing as a contributor and the Shen Lin, Peking University line removed.SummaryDifference2%

- Check16 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates the page content has been updated since the last revision.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer revision of the page text.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a site/version change rather than an update to the clinical trial record.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision: v3.5.0 has been added. Revision: v3.4.3 has been removed.SummaryDifference0.1%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.